Ratio Analysis: Unpacking Teva- Pharmaceutical Industries Ltd. ADR (TEVA)’s Price-to-Cash and Price-to-Free Cash Flow

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 7.48 million shares were traded. TEVA stock price reached its highest trading level at $13.0887 during the session, while it also had its lowest trading level at $12.86.

Ratios:

Our goal is to gain a better understanding of TEVA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.52 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.29. For the most recent quarter (mrq), Quick Ratio is recorded 0.69 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 2.70 whereas as Long-Term Debt/Eq ratio is at 2.46.

On February 12, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $12 to $19.

Jefferies Upgraded its Hold to Buy on January 23, 2024, whereas the target price for the stock was revised from $10 to $14.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 06 ’24 when Kalif Eliyahu Sharon sold 77,550 shares for $13.52 per share. The transaction valued at 1,048,119 led to the insider holds 203,691 shares of the business.

Sabag Mark sold 100,000 shares of TEVA for $1,352,090 on Mar 05 ’24. The EVP, International Markets now owns 382,590 shares after completing the transaction at $13.52 per share. On Mar 05 ’24, another insider, Daniell Richard, who serves as the Exec. VP, European Commercial of the company, sold 48,629 shares for $13.52 each. As a result, the insider received 657,240 and left with 69,770 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 14735646720 and an Enterprise Value of 32252432384. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.92 while its Price-to-Book (P/B) ratio in mrq is 1.94. Its current Enterprise Value per Revenue stands at 2.035 whereas that against EBITDA is 7.443.

Stock Price History:

Over the past 52 weeks, TEVA has reached a high of $14.47, while it has fallen to a 52-week low of $7.09. The 50-Day Moving Average of the stock is -3.44%, while the 200-Day Moving Average is calculated to be 21.40%.

Shares Statistics:

The stock has traded on average 10.21M shares per day over the past 3-months and 9648680 shares per day over the last 10 days, according to various share statistics. A total of 1.12B shares are outstanding, with a floating share count of 1.12B. Insiders hold about 0.01% of the company’s shares, while institutions hold 52.49% stake in the company. Shares short for TEVA as of 1711584000 were 11555241 with a Short Ratio of 1.13, compared to 1709164800 on 14720314.

Dividends & Splits

The stock’s 5-year Average Dividend Yield is 2.95.

Most Popular

[the_ad id="945"]